Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Wave Life Sciences (WVE) over the last 9 years, with Q3 2025 value amounting to $10.0 million.

  • Wave Life Sciences' Receivables - Net changed N/A to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year change of. This contributed to the annual value of $1.4 million for FY2024, which is 9325.62% down from last year.
  • Wave Life Sciences' Receivables - Net amounted to $10.0 million in Q3 2025.
  • Over the past 5 years, Wave Life Sciences' Receivables - Net peaked at $30.0 million during Q1 2021, and registered a low of $1.3 million during Q2 2024.
  • Over the past 4 years, Wave Life Sciences' median Receivables - Net value was $8.5 million (recorded in 2023), while the average stood at $11.9 million.
  • Its Receivables - Net has fluctuated over the past 5 years, first plummeted by 9325.62% in 2024, then skyrocketed by 2534.88% in 2025.
  • Over the past 4 years, Wave Life Sciences' Receivables - Net (Quarter) stood at $22.5 million in 2021, then fell by 6.28% to $21.1 million in 2023, then tumbled by 93.26% to $1.4 million in 2024, then soared by 603.23% to $10.0 million in 2025.
  • Its Receivables - Net was $10.0 million in Q3 2025, compared to $1.6 million in Q2 2025 and $1.4 million in Q4 2024.